 
        
            Gilead, Global Fund finalise plan to supply HIV prevention drug to poor countries
Gilead Sciences in Oceanside, California, USA. – AFP Gilead Sciences and the Global Fund to combat AIDS, tuberculosis and malaria on Wednesday that they had completed plans to deliver a long-acting HIV prevention medication to countries with a low income, despite the absence of financing an important US initiative aimed at tackling worldwide HIV/AIDS epidemic….


 
         
         
         
         
         
         
         
         
         
        